Increased cardiovascular risk associated with diabetes in Dallas County

American Heart Journal

Volumn 151, Issue 5, 2006, Pages 1087-1093

  Das, Sandeep R ^a   Vaeth, Patrice A C ^a   Stanek, Harold G ^a   de Lemos, James A ^a   Dobbins, Robert L ^a   McGuire, Darren K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; UNITED STATES;

EID: 33748686769     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.06.037     Document Type: Article

References (26)

1. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
2. Schmidt M.I., Duncan B.B., Vigo A., et al. Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study. Diabetes Care 26 (2003) 1338-1343
3. Fox C.S., Coady S., Sorlie P.D., et al. Trends in cardiovascular complications of diabetes. JAMA 292 (2004) 2495-2499
4. Saydah S.H., Loria C.M., Eberhardt M.S., et al. Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 24 (2001) 447-453
5. Taubert G., Winkelmann B.R., Schleiffer T., et al. Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145 (2003) 285-291
6. Muhlestein J.B., Anderson J.L., Horne B.D., et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 146 (2003) 351-358
7. Norhammar A., Tenerz A., Nilsson G., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359 (2002) 2140-2144
8. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 27 (2004) S15-S35
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
10. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
11. Saaddine J.B., Engelgau M.M., Beckles G.L., et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 136 (2002) 565-574
12. Victor R.G., Haley R.W., Willett D.L., et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 93 (2004) 1473-1480
13. American College of Sports Medicine. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 30 (1998) 975-991
14. 1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 21 (1998) 1221-1225
15. 1c and fructosamine. Diabetes Care 26 (2003) 163-167
16. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
17. Sayad D.E., Willett D.L., Bridges W.H., et al. Noninvasive quantitation of left ventricular wall thickening using cine magnetic resonance imaging with myocardial tagging. Am J Cardiol 76 (1995) 985-989
18. Harris M.I., Eastman R.C., Cowie C.C., et al. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 20 (1997) 1859-1862
19. Guerci A.D., Spadaro L.A., Popma J.J., et al. Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults. Am J Cardiol 79 (1997) 128-133
20. Raggi P., Shaw L.J., Berman D.S., et al. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 43 (2004) 1663-1669
21. Bolick L.E., and Blankenhorn D.H. A quantitative study of coronary arterial calcification. Am J Pathol 39 (1961) 511-519
22. Greenland P., LaBree L., Azen S.P., et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291 (2004) 210-215
23. Hurst R.T., and Lee R.W. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 139 (2003) 824-834
24. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 321 (1989) 129-135
25. Collins R., Armitage J., Parish S., et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
26. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355 (2000) 253-259